Structural Determinants of the Dictyostatin Chemotype for Tubulin Binding Affinity and Antitumor Activity Against Taxane- and Epothilone-Resistant Cancer Cells

A combined biochemical, structural, and cell biology characterization of dictyostatin is described, which enables an improved understanding of the structural determinants responsible for the high-affinity binding of this anticancer agent to the taxane site in microtubules (MTs). The study reveals that this macrolide is highly optimized for MT binding and that only a few of the structural modifications featured in a library of synthetic analogues resulted in small gains in binding affinity. The high efficiency of the dictyostatin chemotype in overcoming various kinds of clinically relevant resistance mechanisms highlights its potential for therapeutic development for the treatment of drug-resistant tumors. A structural explanation is advanced to account for the synergy observed between dictyostatin and taxanes on the basis of their differential effects on the MT lattice. The X-ray crystal structure of a tubulin–dictyostatin complex and additional molecular modeling have allowed the rationalization of the structure–activity relationships for a set of synthetic dictyostatin analogues, including the highly active hybrid 12 with discodermolide. Altogether, the work reported here is anticipated to facilitate the improved design and synthesis of more efficacious dictyostatin analogues and hybrids with other MT-stabilizing agents.

• Publication year

  2016

• Venue

  ACS Omega

• Publication date

  2016-12-13

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/acsomega.6b00317PMID 30023505PMCID 6044705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A "methyl extension" strategy for polyketide natural product linker site validation and its application to dictyostatin.

  2015cited by this paper
• Conformation-activity relationships of polyketide natural products.

  2015cited by this paper
• Molecular recognition of epothilones by microtubules and tubulin dimers revealed by biochemical and NMR approaches.

  2014cited by this paper
• PM060184, a new tubulin binding agent with potent antitumor activity including P-glycoprotein over-expressing tumors.

  2014cited by this paper
• High-resolution microtubule structures reveal the structural transitions in αβ-tubulin upon GTP hydrolysis.

  2014cited by this paper
• Structural basis of microtubule stabilization by laulimalide and peloruside A.

  2014cited by this paper
• Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents

  2013cited by this paper
• Structural basis of tubulin tyrosination by tubulin tyrosine ligase

  2013cited by this paper
• The binding sites of microtubule-stabilizing agents.

  2013cited by this paper
• Comparative Binding Energy (COMBINE) Analysis Supports a Proposal for the Binding Mode of Epothilones to β‐Tubulin

  2012cited by this paper
• Overcoming tumor multidrug resistance using drugs able to evade P‐glycoprotein or to exploit its expression

  2012cited by this paper
• MM-ISMSA: An Ultrafast and Accurate Scoring Function for Protein-Protein Docking.

  2012cited by this paper
• Linking Crystallographic Model and Data Quality

  2012cited by this paper
• H++ 3.0: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations

  2012cited by this paper
• R.E.D. Server: a web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments

  2011cited by this paper
• A Simplified Synthesis of Novel Dictyostatin Analogues with In Vitro Activity against Epothilone B–Resistant Cells and Antiangiogenic Activity in Zebrafish Embryos

  2011cited by this paper
• Dictyostatin flexibility bridges conformations in solution and in the β-tubulin taxane binding site.

  2011cited by this paper
• Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells

  2011cited by this paper
• Modulation of microtubule interprotofilament interactions by modified taxanes.

  2011cited by this paper
• Highly Stereoselective Total Synthesis of (+)‐9‐epi‐Dictyostatin and (–)‐12,13‐Bis‐epi‐dictyostatin

  2011cited by this paper
• Total synthesis and biological evaluation of a series of macrocyclic hybrids and analogues of the antimitotic natural products dictyostatin, discodermolide, and taxol.

  2011cited by this paper
• Microtubule-binding agents: a dynamic field of cancer therapeutics

  2010cited by this paper
• Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin.

  2010cited by this paper
• Total synthesis of novel dictyostatin analogs and hybrids as microtubule-stabilizing anticancer agents

  2009cited by this paper
• Class III β-tubulin expression and in vitro resistance to microtubule targeting agents

  2009cited by this paper
• Total synthesis and biological evaluation of novel C2-C6 region analogues of dictyostatin.

  2009cited by this paper
• Staggered Mesh Ewald: An extension of the Smooth Particle-Mesh Ewald method adding great versatility.

  2009cited by this paper
• Ixabepilone: targeting βIII-tubulin expression in taxane-resistant malignancies

  2009cited by this paper
• Total synthesis of a potent hybrid of the anticancer natural products dictyostatin and discodermolide.

  2008cited by this paper
• The roles of cys124 and ser239 in the functional properties of human betaIII tubulin.

  2008cited by this paper
• Synthesis and biological evaluation of 10,11-dihydrodictyostatin, a potent analogue of the marine anticancer agent dictyostatin.

  2008cited by this paper
• The bound conformation of microtubule-stabilizing agents: NMR insights into the bioactive 3D structure of discodermolide and dictyostatin.

  2008cited by this paper
• Optimization of taxane binding to microtubules: binding affinity dissection and incremental construction of a high-affinity analog of paclitaxel.

  2008cited by this paper
• Development of practical syntheses of the marine anticancer agents discodermolide and dictyostatin.

  2008cited by this paper
• Characterizing ligand-microtubule binding by competition methods.

  2007cited by this paper
• Total synthesis and biological evaluation of C16 analogs of (-)-dictyostatin.

  2007cited by this paper
• Design, synthesis and biological evaluation of a macrocyclic discodermolide/dictyostatin hybrid.

  2007cited by this paper
• Overcoming Tumor Drug Resistance with High‐Affinity Taxanes: A SAR Study of C2‐Modified 7‐Acyl‐10‐Deacetyl Cephalomannines

  2007cited by this paper
• Synthesis and biological evaluation of novel analogues of dictyostatin.

  2007cited by this paper
• Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines.

  2007cited by this paper
• Synergistic Effects of Peloruside A and Laulimalide with Taxoid Site Drugs, but Not with Each Other, on Tubulin Assembly

  2006cited by this paper
• Potentiation of Taxol Efficacy by Discodermolide in Ovarian Carcinoma Xenograft-Bearing Mice

  2006cited by this paper
• Microtubule interactions with chemically diverse stabilizing agents: thermodynamics of binding to the paclitaxel site predicts cytotoxicity.

  2005cited by this paper
• Synthesis and biological evaluation of (-)-16-normethyldictyostatin: a potent analogue of (-)-dictyostatin.

  2005cited by this paper
• Total Synthesis of (+)‐Discodermolide: An Improved Endgame Exploiting a Still—Gennari‐Type Olefination with a C1—C8 β‐Ketophosphonate Fragment.

  2005cited by this paper
• MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes

  2004cited by this paper
• A phase I pharmacokinetic (PK) trial of XAA296A (Discodermolide) administered every 3 wks to adult patients with advanced solid malignancies.

  2004cited by this paper
• Total synthesis and configurational assignment of (-)-dictyostatin, a microtubule-stabilizing macrolide of marine sponge origin.

  2004cited by this paper
• Synergistic Suppression of Microtubule Dynamics by Discodermolide and Paclitaxel in Non-Small Cell Lung Carcinoma Cells

  2004cited by this paper
• Total synthesis of (+)-discodermolide: an improved endgame exploiting a Still-Gennari-type olefination with a C1-C8 beta-ketophosphonate fragment.

  2004cited by this paper
• Interaction of epothilone analogs with the paclitaxel binding site: relationship between binding affinity, microtubule stabilization, and cytotoxicity.

  2004cited by this paper
• Tubulin polymerizing activity of dictyostatin-1, a polyketide of marine sponge origin.

  2003cited by this paper
• The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity.

  2002cited by this paper
• Hydrogen bridges in crystal engineering: interactions without borders.

  2002cited by this paper
• Refined structure of alpha beta-tubulin at 3.5 A resolution.

  2001cited by this paper
• Refined structure of αβ-tubulin at 3.5 Å resolution 1 1Edited by I. A. Wilson

  2001cited by this paper
• Solution structure of (+)-discodermolide.

  2001cited by this paper
• Discodermolide: just another microtubule-stabilizing agent? No! A lesson in synergy.

  2000cited by this paper
• Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.

  2000cited by this paper
• Molecular Recognition of Taxol by Microtubules

  2000cited by this paper
• Gram-scale synthesis of (+)-discodermolide.

  2000cited by this paper
• Gram-Scale Synthesis of (+)-Discodermolide.

  1999cited by this paper
• The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.

  1997cited by this paper
• Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven Polymerization*

  1997cited by this paper
• Inhibition of microtubules and cell cycle arrest by a new 1-deaza-7,8-dihydropteridine antitumor drug, CI 980, and by its chiral isomer, NSC 613863.

  1994cited by this paper
• Thermodynamics of ligand-induced assembly of tubulin.

  1993cited by this paper
• Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition.

  1993cited by this paper
• Low resolution structure of microtubules in solution. Synchrotron X-ray scattering and electron microscopy of taxol-induced microtubules assembled from purified tubulin in comparison with glycerol and MAP-induced microtubules.

  1992cited by this paper
• Discodermolide: a new bioactive polyhydroxylated lactone from the marine sponge Discodermia dissoluta

  1990cited by this paper
• The expected effect of a combination of agents: the general solution.

  1985cited by this paper
• Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine.

  1985cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984cited by this paper
• Comparison of simple potential functions for simulating liquid water

  1983cited by this paper
• Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes

  1977cited by this paper

• A Review on the Microtubule Inhibitory Effects of Active Ingredients Extracted from TCMs and Ethnic Medicines in Cancer Treatment.

  2025cites this paper
• Microtubule inhibition as a proposed mechanism for the anthelmintic effect of phytochemicals isolated from Cicerbita alpina

  2025cites this paper
• Exploring tubulin-paclitaxel binding modes through extensive molecular dynamics simulations

  2025cites this paper
• Structural insight into the stabilization of microtubules by taxanes

  2022cites this paper
• Microtubule-Inspired Functionalization of Carbon Nanotubes: A Biomimetic Carrier Design

  2022cites this paper
• Chemical modulation of microtubule structure through the laulimalide/peloruside site.

  2022influential citation
• Crystal structures of taxane-tubulin complexes: Implications for the mechanism of microtubule stabilization by Taxol

  2021cites this paper
• Development of novel derivatives of stilbene and macrocyclic compounds as potent of anti-microtubule factors.

  2021cites this paper
• Microtubule-targeting agents and neurodegeneration.

  2020cites this paper
• MARINE NATURAL PRODUCTS WITH HIGH ANTICANCER ACTIVITIES.

  2020cites this paper
• High-resolution X-ray structure of three microtubule-stabilizing agents in complex with tubulin provide a rationale for drug design.

  2020cites this paper
• Fighting cancer with microtubule-stabilizing agents: a computational investigation of the complex between β-tubulin and the microtubule-stabilizing, antitumor marine diterpenoid sarcodictyin A

  2019cites this paper
• Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands

  2019influential citation
• Computational Prediction of the Mode of Binding of Antitumor Lankacidin C to Tubulin

  2019cites this paper
• An overview of tubulin modulators deposited in protein data bank

  2019cites this paper
• Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule

  2019cites this paper
• Evaluation of antioxidant activity and cytotoxicity of polyfluorinated diarylacetylenes and indoles toward human cancer cells

  2019cites this paper
• Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural products.

  2019cites this paper
• A Series of Enthalpically Optimized Docetaxel Analogues Exhibiting Enhanced Antitumor Activity and Water Solubility.

  2018cites this paper
• Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target

  2018cites this paper
• Copper-Catalyzed Syntheses of Pyrene-Pyrazole Pharmacophores and Structure Activity Studies for Tubulin Polymerization

  2018cites this paper
• Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton.

  2018cites this paper
• Macrocycles All Aflutter: Substitution at an Allylic Center Reveals the Conformational Dynamics of [13]-Macrodilactones.

  2017cites this paper
• Structural Basis of Microtubule Stabilization by Discodermolide

  2017cites this paper